UOTTAIMCU
RPRX icon

University of Texas/Texas AM Investment Management Co (UTIMCO)’s Royalty Pharma RPRX Stock Holding History

University of Texas/Texas AM Investment Management Co (UTIMCO)’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-47,786
Closed -$1.22M – 206
2024
Q4 		$1.22M Buy
+47,786
New +$1.27M 0.14% 70

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

University of Texas/Texas AM Investment Management Co (UTIMCO)'s RPRX Position: Q1 2025 in Review

University of Texas/Texas AM Investment Management Co (UTIMCO) sold out of Royalty Pharma (RPRX) in Q1 2025, closing a stake of 47,786 shares — an estimated $1.22M sold.

University of Texas/Texas AM Investment Management Co (UTIMCO) first reported a position in RPRX in Q4 2024 and held it in 1 quarter. The position peaked at $1.22M in Q4 2024. 447 funds tracked by Wall St. Rank hold RPRX as of Q1 2025.

  • University of Texas/Texas AM Investment Management Co (UTIMCO) reported no remaining Royalty Pharma position as of Q1 2025 after selling out during the quarter.
  • University of Texas/Texas AM Investment Management Co (UTIMCO) sold 47,786 Royalty Pharma shares in Q1 2025, an estimated $1.22M.
  • University of Texas/Texas AM Investment Management Co (UTIMCO) first reported a position in Royalty Pharma in Q4 2024 and held it in 1 quarter.
  • University of Texas/Texas AM Investment Management Co (UTIMCO)'s Royalty Pharma position peaked at $1.22M in Q4 2024.
  • 447 funds tracked by Wall St. Rank held Royalty Pharma as of Q1 2025.

Based on University of Texas/Texas AM Investment Management Co (UTIMCO)'s 13F filing for Q1 2025, filed 7 May 2025.